We conducted a systematic review and a meta-analysis to assess the association of
anticoagulants and their dosage with in-hospital all-cause mortality in COVID-19 patients …

Background: Coagulopathy and thromboembolic events are common in Covid‐19 patients
and are poor prognostic factors. Controversy exists regarding the potential of …

Coronavirus disease 2019 (COVID-19)-associated coagulopathy (CAC), characterized by
hypercoagulability and an increased risk of thrombotic complications, is an important …

Patients with COVID-19 are known to be at risk of developing both venous, arterial and
microvascular thrombosis, due to an excessive immuno-thrombogenic response to the …

Background: COVID-19-associated coagulopathy (CAC) exacerbates the course of
coronavirus infection and contributes to increased mortality. Current recommendations for …

Coronavirus disease (COVID-19) infection was declared a public health emergency of
international concern in January 2020. The medical literature has since seen a succession …

Purpose To assess the safety and efficacy of embolization for spontaneous bleeding in
anticoagulated patients with COVID-19. Material and Methods Single center retrospective …

Background and Objectives: Increasing attention is being paid to the coagulation disorders
associated with SARS-CoV-2 infection. Bleeding accounts for 3–6% of COVID-19 patient …

While the COVID-19 pandemic sweeps the world, much evidence is being gathered
regarding its novel pathological mechanisms. It is the authors' clinical experience that …

Method: A retrospective study examined CT scans performed over a 13-month period in
patients hospitalised with COVID-19 infection to determine those who developed …